Get started Log in

BIM — Biomerieux SA Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Market Cap
€8.60bn
Enterprise Value
€8.49bn
Revenue
€4.07bn

Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Tue 15:29
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
04/06/2026 17:28
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
01/06/2026 11:26
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
29/05/2026 15:33
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
29/05/2026 12:00
Factbox: Bundibugyo Ebola vaccines and treatments in development
22/05/2026 21:12
Factbox: Bundibugyo Ebola vaccines and treatments in development
22/05/2026 17:39
Factbox: Bundibugyo Ebola vaccines and treatments in development
21/05/2026 18:43
Test shortages slow fight against Ebola in Congo, WHO official says (updated)
19/05/2026 13:23
Brief: L'Institut Merieux: bought an extra 1% in BioMerieux, bringing its total stake in company to around 60%
06/05/2026 17:37
DiaSorin falls as Qiagen cuts outlook on QuantiFERON weakness
28/04/2026 09:44
Europe Research Roundup: BESI, Saipem, Vossloh
24/04/2026 08:01
BioMerieux shares slump on 'bad' sales miss, outlook cut
23/04/2026 08:37
Brief: Biomerieux Q1 Sales EUR 984 Million
23/04/2026 06:25
Brief: BioMerieux Gets IVDR CE‑Marking For 2 Biofire Spotfire Panels
19/03/2026 06:06
BioMerieux rebounds from 1.5-year lows as 2026 forecasts reassure
27/02/2026 09:36
Brief: BioMerieux Eyes 2026 Sales Growth Of 5-7% LFL
27/02/2026 05:54
Brief: Biomerieux Acquires U.S. Firm Accellix For EUR 35 Mln
22/01/2026 07:35
Midcap ups bioMérieux to 'buy' on 'exceptional' U.S. flu season
20/01/2026 10:58
Europe Research Roundup: Beiersdorf, Neste, RS Group
15/12/2025 07:38